CLQFG - G-135 INDUSTRIAL X-RAY DEVELOPER/REPLENISHER PART A

  • MSDS: CLQFG
  • Manufacturer: AGFA CORP
  • Product Name: G-135 INDUSTRIAL X-RAY DEVELOPER/REPLENISHER PART A
  • National Stock Number: 6750-01-461-5235
Product Identification

Product ID:G-135 INDUSTRIAL X-RAY DEVELOPER/REPLENISHER PART A
MSDS Date:03/24/2000
FSC:6750
NIIN:01-461-5235
Status Code:A
Kit Part:Y
MSDS Number: CLQFG

Responsible Party
AGFA CORPORATION
100 CHALLENGER RD
RIDGEFIELD PARK, NJ 07660
US

Emergency Phone: (303) 623-5716 HEALTH

Info Phone: 201-440-2500

Preparer: S. VAN VOLKENBURG

Cage: 1MVW0

Contractor
AGFA CORPORATION
RIDGEFIELD PARK, NJ 07660 US

Telephone: 201-440-2500

Cage: 1MVW0

Ingredients

HYDROQUINONE

CAS: 123-31-9

RTECS: MX3500000

OSHA PEL 2 MG/M3

ACGIH TLV: 2 MG/M3

EPA Report Quantity: 1 LB

DOT Report Quantity: 1 LB


POTASSIUM BROMIDE

CAS: 7758-02-3

RTECS: TS7650000


POTASSIUM SULFITE

CAS: 10117-38-1


SODIUM TETRABORATE

CAS: 1303-96-4

RTECS: VZ2275000

ACGIH TLV: 5 MG/M3

Hazards

Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:ACUTE: EXPOSURE MAY CAUSE EYE, SKIN &
RESPIRATORY TRACT IRRITATION. MAY CAUSE ALLERGIC SKIN REACTION.
INGESTION MAY CAUSE IRRITATION OF GI TRACT. SULFITE SENSITIVE
PERSONS MAY SUFFER ALLERGIC REACTION . CHRONIC: PROLONGED/ REPEATED
EXPOSURE MAY CAUSE SKIN SENSITIZATION/ DERMATITIS, ANEMIA,
INTOLERANCE TO LIGHT, CORNEAL PIGMENTATION, SOME ASTHMATICS AND
SULFITE SENSITIVE PERSONS MAY SUFFER ALLERGIC REACTIONS.
Explanation of Carcinogenicity:THE COMPONENTS OF THIS PRODUCT ARE NOT
LISTED BY NTP, IARC OR REGULATED AS A CARCINOGEN BY OSHA.
Effects of Overexposure:ACUTE INHALATION: HYDROQUINONE, POTASSIUM
SULFITE, AND POTASSIUM BROMIDE MAY CAUSE IRRITATION WITH SYMPTOMS
OF COUGHING, SORE THROAT, AND RUNNY NOSE. CHRONIC INHALATION:
SULFITES MAY CAUSE AN ALLERGI C REACTION IN SOME ASTHMATICS AND
SULFITE SENSITIVE INDIVIDUALS. POSSIBLE SYMPTOMS INCLUDE
BRONCHOCONSTRICTION, SWEATING, FLUSHING, HIVES, RAPID HEART RATE,
DECREASED BLOOD PRESSURE, AND ANAPHYLAXIS. PROLONGED INHALATION OF
POTASSIUM BROMIDE MAY CAUSE SKIN ERUPTIONS. ACUTE SKIN CONTACT:
HYDROQUINONE, POTASSIUM SULFITE, ANDPOTASSIUM BROMIDE MAY BE
IRRITATING TO THE SKIN WITH SYMPTOMS OF REDDENING A ND ITCHING.
Medical Cond Aggravated by Exposure:PERSONS WITH PREEXISTING EYE OR
SKIN CONDITIONS OR IMPAIRED PULMONARY FUNCTION MAY BE MORE
SUSCEPTIBLE TO THE EFFECTS OF THIS PRODUCT.

First Aid

First Aid:EYE: IMMEDIATELY FLUSH EYES WITH PLENTY OF WATER FOR AT LEAST
15 MINUTES. CALL A PHYSICIAN. SKIN: REMOVE CONTAMINATED CLOTHING,
IMMEDIATELY WASH SKIN WITH PLENTY OF WATER. WASH CLOTHING BEFORE
REUSE. CALL A PHYSICIAN IF IRRITATION PERSISTS. INHALATION:
REMOVE TO FRESH AIR. IF NOT BREATHING, GIVE ARTIFICIAL RESPIRATION.
IF BREATHING IS DIFFICULT, GIVE OXYGEN. CALL A PHYSICIAN.
INGESTION: DRINK 1-2 GLASSES OF WATER. NEVER GIVE ANYTHING BY
MOUTH TO AN UNCONSCIOUS PERSON. SEEK MEDICAL ATTENTION. TAKE THIS
MSDS TO PHYSICIAN.

Fire Fighting

Flash Point:NONCOMBUSTIBLE
Extinguishing Media:MATERIAL IS NOT COMBUSTIBLE. USE EXTINGUISHING
MEDIA SUITABLE FOR OTHER COMBUSTIBLE MATERIALS IN THE AREA.
Fire Fighting Procedures:EVACUATE PERSONNEL TO A SAFE AREA. KEEP
PERSONNEL REMOVED AND UPWIND OF FIRE. WEAR SELF-CONTAINED BREATHING
APPARATUS.

Accidental Release

Spill Release Procedures:USE APPROPRIATE PERSONAL PROTECTIVE EQUIPMENT
DURING CLEAN UP. DIKE SPILL. PREVENT LIQUID FROM ENTERING SEWERS,
WATERWAYS OR LOW AREAS. SOAK UP WITH SAWDUST, SAND, OIL DRY OR
OTHER ABSORBENT MATERIAL. SPILL MAY BE NEUTRALIZED WITH POWDERED
CITRIC ACID.
Neutralizing Agent:SPILL MAY BE NEUTRALIZED WITH POWDERED CITRIC ACID.

Handling

Handling and Storage Precautions:STORE BETWEEN 40F (4.4C) AND 80F
(26C). PREFERRED STORAGE IS AT 68F (20C). KEEP FROM FREEZING. AVOID
EYE AND SKIN CONTACT, AND STORE IN WELL-VENTILATED AREA. KEEP
CONTAINER TIGHTLY CLOSED. DO NOT STOR E WITH INCOMPATIBLE
MATERIALS.
Other Precautions:DO NOT STORE OR CONSUME FOOD, DRINK OR TOBACCO IN
AREA WHERE THEY MAY BECOME CONTAMINATED WITH THIS MATERIAL. KEEP
OUT OF REACH OF CHILDREN.

Exposure Controls

Respiratory Protection:UNDER NORMAL CONDITIONS OF USE, RESPIRATOR
PROTECTION IS NOT REQUIRED. IF RESPIRATORS ARE USED, INSTITUTE A
PROGRAM IN ACCORDANCE WITH OSHA STANDARD 29CFR1010.134.
Ventilation:USE SUFFICIENT GENERAL ROOM VENTILATION AND/OR LOCAL
EXHAUST TO MAINTAIN AIRBORNE LEVELS OF VAPORS BELOW APPLICABLE
EXPOSURE LIMITS.
Protective Gloves:USE CHEMICAL RESISTANT GLOVES
Eye Protection:EYE GLASSES WITH SIDE SHIELDS OR GOGGLES
Other Protective Equipment:EMERGENCY SHOWERS AND EYE WASH STATIONS
SHOULD BE MADE AVAILABLE. EDUCATE AND TRAIN EMPLOYEES IN THE SAFE
USE AND HANDLING OF THIS PRODUCT. FOR SKIN PROTECTION USE CHEMICAL
RESISTANT APRONS.
Supplemental Safety and Health
PART A OF A 4 PART KIT, SAME NSN.

Chemical Properties

HCC:B3
Boiling Pt:=100.C, 212.F
B.P. Text:APPROX.
Melt/Freeze Pt:=0.C, 32.F
M.P/F.P Text:APPROX.
Spec Gravity:APPROX. 1.3
pH:APPROX. 11.9
Solubility in Water:SOLUBLE
Appearance and Odor:CLEAR LIGHT YELLOW LIQUID; ODORLESS

Stability

Stability Indicator/Materials to Avoid:YES
STRONG ACIDS, OXIDIZERS.
Stability Condition to Avoid:NONE KNOWN.
Hazardous Decomposition Products:IN CASE OF FIRE, OXIDES OF SULFUR,
CO2, CARBON MONOXIDE AND OTHER POTENTIALLY TOXIC FUMES.
Conditions to Avoid Polymerization:WILL NOT OCCUR.

Disposal

Waste Disposal Methods:RECOVER NONUSABLE FREE LIQUID AND/OR
CONTAMINATED WATER, AND DISPOSE OF IN AN APPROVED AND PERMITTED
TREATMENT SYSTEM. REMOVE NONUSABLE SOLID MATERIAL AND/OR
CONTAMINATED SOIL, FOR DISPOSAL IN AN APPR OVED AND PERMITTED
LANDFILL. DISCHARGE TO SEWER MAY REQUIRE APPROVAL OF PERMITTING
AUTHORITY AND MAY REQUIRE PRETREATMENT.

Toxicology

Toxicological Information:HYDROQUINONE: LD50 ORAL RAT = 320 MG/KG, SKIN
EFFECTS: 2% - MILD (HUMAN), 5% - SEVERE (HUMAN). ORAL LDL0 (HUMAN)
= 29 MG/KG. CHRONIC TOXICITY: ADVERSE KIDNAY EFFECTS HAVE BEEN
OBSERVED PRIMARILY IN O NE STRAIN OF MALE RAT (F-344) FOLLOWING
CHRONIC ADMINISTRATION OF ORAL DOSES. CARCINOGENICITY: FORMATION OF
BENIGN KIDNEY TUMORS OCCURRED ONLY AFTER NEPHROPATHY DEVELOPED AND
ONLY IN ONE STRAIN OF MAL E RATS. MUTAGENICITY: AMES TEST WAS
NEGATIVE. DEVELOPMENTAL TOXICITY:HAS NOT CAUSED BIRTH DEFECTS.
REPRODUCTIVE EFFECTS: HAS NOT CAUSED REPRODUCTIVE EFFECTS IN MALE
AND FEMALE ANIMALS.

Other Information

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ecology

Ecological:NO INFO AVAILABLE.

Transport

Transport Information:NOT REGULATED BY ALL MODES OF TRANSPORTATION.

Regulatory

SARA Title III Information:SEC 302 EHS: HYDROQUINONE 5-10%. SEC 311/312
HAZ CATEGORIES: IMMEDIATE AND DELAYED HEALTH HAZARDS. SEC 313 TOXIC
CHEMICALS:HYDROQUINONE 5-10%. RCRA STATUS: IF RELEASED IN ITS
PURCHASED FORM, THIS PROD UCT WOULD NOT BE A HAZARDOUS WASTE EITHER
BY LISTING OR BY CHARACTERISTICS.
Federal Regulatory Information:TSCA INVENTORY STATUS: IS LISTED ON THE
TSCA INVENTORY. OSHA STATUS: THIS PRODUCT IS HAZARDOUS UNDER THE
CRITERIA OF THE FEDERAL OSHA HAZARD COMMUNICATION STANDARD 29 CFR
1910.1200.
State Regulatory Information:INGREDIENTS ARE LISTED BY THE FOLLOWING
STATES: NJ, PA, MA.